Qingdao Baheal Medical INC. (SHE:301015)
China flag China · Delayed Price · Currency is CNY
23.71
-1.11 (-4.47%)
Nov 17, 2026, 3:04 PM CST

SHE:301015 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Operating Revenue
7,0717,4808,0688,2267,4947,030
Other Revenue
26.6726.6726.0329.9615.1922
7,0987,5078,0948,2567,5107,052
Revenue Growth
-6.34%-7.26%-1.96%9.94%6.50%19.94%
Cost of Revenue
4,3974,7415,2285,5055,4265,277
Gross Profit
2,7002,7662,8662,7512,0841,774
Selling, General & Admin
2,0451,9471,7971,5951,3191,130
Research & Development
68.3742.1736.1442.453.32-
Other Operating Expenses
53.8845.639.327.9436.0531.54
Operating Expenses
2,1802,0421,8841,6981,3711,160
Operating Income
520.28723.41981.911,053712.6614.75
Interest Expense
-113.98-103.65-80.09-71.73-58.07-61.08
Interest & Investment Income
31.1330.6872.8457.039.4410.92
Currency Exchange Gain (Loss)
-12.87-12.87-2.88-2.96.42-2.38
Other Non Operating Income (Expenses)
9.35-1.89-12.93-8.9-4.99-15.22
EBT Excluding Unusual Items
433.91635.67958.861,026665.4547
Gain (Loss) on Sale of Investments
-55.2573.36-6.590.62-10.755.87
Gain (Loss) on Sale of Assets
0.70.520.93-6.570.570.1
Asset Writedown
26.8-0.6-0.46-0.35-0.04-0.01
Other Unusual Items
11.6214.0313.898.2613.3812.46
Pretax Income
417.78722.98966.631,028668.55565.42
Income Tax Expense
95.36151.05199.6257.26183.15150.4
Earnings From Continuing Operations
322.42571.93767.03770.73485.4415.02
Minority Interest in Earnings
-84.58-97.24-75.44-58.6716.686.63
Net Income
237.85474.69691.59712.06502.09421.64
Net Income to Common
237.85474.69691.59712.06502.09421.64
Net Income Growth
-54.87%-31.36%-2.87%41.82%19.08%54.61%
Shares Outstanding (Basic)
525527524524523496
Shares Outstanding (Diluted)
525533540535523496
Shares Change
-3.35%-1.29%0.92%2.37%5.44%5.50%
EPS (Basic)
0.450.901.321.360.960.85
EPS (Diluted)
0.450.891.281.330.960.85
EPS Growth
-53.31%-30.47%-3.76%38.54%12.94%46.55%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Free Cash Flow
290.34645.52509.86614.01200.43153.81
Free Cash Flow Per Share
0.551.210.941.150.380.31
Dividend Per Share
0.5710.5710.762-0.7620.667
Dividend Growth
-25.07%-25.07%--14.24%-
Gross Margin
38.05%36.84%35.41%33.32%27.75%25.16%
Operating Margin
7.33%9.64%12.13%12.75%9.49%8.72%
Profit Margin
3.35%6.32%8.54%8.63%6.69%5.98%
Free Cash Flow Margin
4.09%8.60%6.30%7.44%2.67%2.18%
EBITDA
594.21792.611,0451,110735.93636.6
EBITDA Margin
8.37%10.56%12.91%13.45%9.80%9.03%
D&A For EBITDA
73.9369.262.8957.6523.3321.85
EBIT
520.28723.41981.911,053712.6614.75
EBIT Margin
7.33%9.64%12.13%12.75%9.49%8.72%
Effective Tax Rate
22.82%20.89%20.65%25.03%27.39%26.60%
Revenue as Reported
7,0987,5078,0948,2567,5107,052
Advertising Expenses
----1.01-